Zai Lab Ltd
ZLAB
44 insider filings · Latest: Aug 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.97 | $998.5K | 1,122,626(D) | View → |
| May 15, 2026 | May 15 1:49 PM | Du Ying | Proposed Sale | 50,000 | $20.46 | $1.0M | — | View → |
| May 14, 2026 | May 14 8:17 PM | Du Ying | Proposed Sale | 50,000 | $20.09 | $1.0M | — | View → |
| May 14, 2026 | May 14 1:50 PM | Edmondson Frazor Titus III | Proposed Sale | 3,517 | $20.19 | $71.0K | — | View → |
| May 13, 2026 | May 13 6:06 PM | Du Ying | Proposed Sale | 50,000 | $19.20 | $960.0K | — | View → |
| Apr 6, 2026 | Apr 8 11:35 PM | Joshua L SmileyPresident and Chief Operating Officer | Sale | 3,017 | $20.45 | $61.7K | 117,602(D) | View → |
| Apr 6, 2026 | Apr 8 11:34 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 1,224 | $20.45 | $25.0K | 23,366(D) | View → |
| Apr 6, 2026 | Apr 8 11:34 PM | Ying DuDirector, Chairperson & CEO | Sale | 2,653 | $20.45 | $54.2K | 1,122,626(D) | View → |
| Apr 6, 2026 | Apr 8 11:33 PM | Yajing ChenChief Financial Officer | Sale | 853 | $20.45 | $17.4K | 31,705(D) | View → |
| Apr 6, 2026 | Apr 8 11:33 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Sale | 2,739 | $20.45 | $56.0K | 57,022(D) | View → |
| Apr 6, 2026 | Apr 6 7:26 PM | Smiley Joshua L | Proposed Sale | 3,017 | $20.45 | $61.7K | — | View → |
| Apr 6, 2026 | Apr 6 7:21 PM | Du Ying | Proposed Sale | 2,653 | $20.45 | $54.2K | — | View → |
| Apr 6, 2026 | Apr 6 7:15 PM | Edmondson Frazor Titus III | Proposed Sale | 1,224 | $20.45 | $25.0K | — | View → |
| Apr 6, 2026 | Apr 6 7:11 PM | Amado Rafael | Proposed Sale | 2,739 | $20.45 | $56.0K | — | View → |
| Apr 6, 2026 | Apr 6 7:04 PM | Chen Yajing | Proposed Sale | 853 | $20.45 | $17.4K | — | View → |
| Apr 2, 2026 | Apr 3 9:59 PM | Joshua L SmileyPresident and Chief Operating Officer | Sale | 9,614 | $20.39 | $196.0K | 120,619(D) | View → |
| Apr 2, 2026 | Apr 3 9:58 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 4,194 | $20.39 | $85.5K | 24,590(D) | View → |
| Apr 2, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Sale | 5,576 | $20.39 | $113.7K | 1,125,279(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Sale | 5,199 | $20.39 | $106.0K | 32,558(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Sale | 9,910 | $20.39 | $202.1K | 59,761(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 822,184(D) | View → |
| Mar 4, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 872,184(D) | View → |
← Previous
Page 3 of 3